Interleukin 8 Is a Surrogate Marker for Rapid Diagnosis of Bacteriuria

REFERENCES

• Agace W., Hedges S., Ceska M., et al. Interleukin-8 and the neutrophil response to mucosal gram – negative infection. J. Clin. Invest. 1993; 92: 780–785
   PubMed Web of Science ®Google Scholar
• Backhed F., Normark S., Schweda E., et al. Structural requirements for TLR4-mediated LPS signaling: a biological role for LPS modifications. Microbes Infect. 2003; 5(12)1057–1063
   PubMed Web of Science ®Google Scholar
• Banas B., Wornle M., Berger T., et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J. Immunol. 2002; 168: 4301–4307
   PubMed Web of Science ®Google Scholar
• Benson M., Jodal U., Agace W., Hellström M., Mårild S., Rosberg S., Sjöström M., Wettergren B., Jönsson S., Svanborg C. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J. Infect. Dis. 1996; 174(5)1080–1084
   PubMed Web of Science ®Google Scholar
• Brown Z., Strieter R. M., Chensue S. W., Ceska M., Lindley I., Neild G. H., Kunkel S. L., Westwick J. Cytokine activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Intl. 1991; 40: 86–90
   PubMed Web of Science ®Google Scholar
• Downs S. M. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999; 103: e54, doi: 10.1542/peds.103.4.e54. [PubMed].
   Google Scholar
• Fleischman J. D., Wentworth D. B., Thomas K. M., Imbembo A. L. Urinary interleukin-2 inhibition in patients with cystitis. Immunol. Invest. 1989; 18: 825–831
   PubMed Web of Science ®Google Scholar
• Galanakis E., Bitsori M., Dimitriou H., et al. Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Pediatrics 2006; 117(5)863–867
   PubMed Web of Science ®Google Scholar
• Haaff E. O., Catalona W. J., Ratliff T. L. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. J. Urol. 1986; 136: 970–974
   PubMed Web of Science ®Google Scholar
• Hedges S., Anderson P., Lidin-Janson G., de Man P., Svanborg-Eden C. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect. Immun. 1991; 59: 421–427
   PubMed Web of Science ®Google Scholar
• Kassir K., Vargas-Shiraishi O., Zaldivar F., et al. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact. Clin. Diagn. Lab. Immunol. 2001; 8(6)1060–1063
   PubMedGoogle Scholar
• Larcombe J. Urinary tract infection. Clinical Evidence. BMJ Publishing, London 2002; 7: 377–385
   Google Scholar
• Matsushima K., Baldwin E. T., Mukaida N. Interleukin- 8 and MCAF: novel leukocyte recruitment and activating cytokines. Urinary tract infection. Chem. Immunol. 1992; 51: 236–265
   PubMedGoogle Scholar
• Olszyna D., Opal S., Prins J., et al. Chemotactic activity of CXC chemokines interleukin IL-8, growth-related oncogene (GRO) and epithelial cell derived neutrophils-activating protein (ENA)-78 in urine of patients with urosepsis. J. Infect Dis. 2000; 182: 1731–1737
   PubMed Web of Science ®Google Scholar
• Rahman P., Gladman D. D., Ibanez D., Urowitz M. B. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus. Lupus 2001; 10(6)418–423
   PubMed Web of Science ®Google Scholar
• Rózsai B., Lányi E., Berki T., Soltész G. Urinary cytokine response to asymptomatic bacteriuria in type 1 diabetic children and young adults. Pediatr. Diabetes 2006; 7(3)153–158
   PubMed Web of Science ®Google Scholar
• Sheu J. N., Chen M. C., Cheng S. L., Lee I. C., Chen S. M., Tsay G. J. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring. Nephrology (Carlton). 2007; 12(5)487–493
   PubMed Web of Science ®Google Scholar
• Taha A., Grant V., Kelly R. Urine analysis for interleukin-8 in the non invasive diagnosis of acute and chronic inflammatory diseases. Postgrad. Med. J. 2003; 79(929)159–163
   PubMed Web of Science ®Google Scholar
• Upadhyay J., Bolduc S., Braga L., Farhat W., Bagli D. J., McLorie G. A., Khoury A. E., El-Ghoneimi A. Impact of prenatal diagnosis on the morbidity associated with ureterocele management. J. Urol. 2002; 167: 2560–2565
   PubMed Web of Science ®Google Scholar
• Vernon S. J., Coulthard M. G., Lambert H. J., Keir M. J., Matthews J. N. New renal scarring in children who at age 3 and 4 years had had normal scans with dimercaptosuccinic acid: follow up study. Br. Med. J. 1997; 315: 905–908, [PubMed]
   PubMedGoogle Scholar
• Whiting P., Westwood M., Bojke L., Palmer S., Richardson G., Cooper J., Watt I., Glanville J., Sculpher M., Kleijnen J. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technol. Assess. 2006; 10(36)iii–iv; xi–xiii; 1–154
   PubMed Web of Science ®Google Scholar
• Yokoyama H., Wada T., Furuichi K., et al. Leucocyte–Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J. Leucoyte Biol. 1998; 63: 493–499
   PubMed Web of Science ®Google Scholar
• Zaki M.-S., Elgendy M. Y., El-Mashad N. B., Farahat M. E. IL-18 level correlates with development of sepsis in surgical patients. Immunol. Invest. 2007; 36(4)403
   PubMed Web of Science ®Google Scholar
• Zorc J. J., Kiddoo D. A., Shaw K. N. Diagnosis and management of pediatric urinary tract infections. Clin. Microbiol. Rev. 2005; 18(2)417–422
   PubMed Web of Science ®Google Scholar